Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jubilant Cadista is the U.S.-focused generic pharmaceuticals business of the Jubilant group, operating as Jubilant Cadista Pharmaceuticals Inc. The company markets and distributes prescription generic finished-dose medicines in the United States and has also shifted part of its operating model toward contract manufacturing and third-party sourcing. It is a subsidiary within Jubilant Pharma/Jubilant Pharmova and is tied to the group's broader generics network, including an FDA-approved manufacturing facility in Roorkee, Uttarakhand, India. The company maintains a corporate office in Yardley, Pennsylvania, while its former Salisbury, Maryland solid oral manufacturing operations were closed. Its business is centered on commercialized generic products rather than a proprietary clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jubilant Cadista.